Alto Neuroscience Inc stock is traded at $21.87, with a volume of 411,272. It is down -6.14% in the last 24 hours and down -8.91% over the past month. Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Previous Close:
$23.30
Open:
$23.06
24h Volume:
411,272
Relative Volume:
0.93
Market Cap:
$858.22M
Revenue:
-
Net Income/Loss:
-$74.31M
P/E Ratio:
-
EPS:
-$2.48
Net Cash Flow:
-$62.86M
1W Performance:
-6.82%
1M Performance:
-8.91%
6M Performance:
-14.07%
1Y Performance:
+93.71%
1-Day Range:
$21.83$23.51
1-Week Range:
$21.50$23.65
52-Week Range:
$10.62$37.48
Alto Neuroscience Inc Stock (ANRO) Company Profile
Name
Alto Neuroscience IncSector
HealthcareIndustry
BiotechnologyPhone
773-255-5012Address
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS